Pentosan Polysulfate vs Phosphate Buffered Saline
A side-by-side research comparison of Pentosan Polysulfate and Phosphate Buffered Saline across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Pentosan Polysulfate | Phosphate Buffered Saline |
|---|---|---|
| Full name | Pentosan Polysulfate Sodium | Phosphate Buffered Saline (PBS) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | FDA Approved | Buffer solvent |
| Mechanism | Acts as a glycosaminoglycan analog that coats bladder mucosa, inhibits complement activation, and stimulates proteoglycan synthesis in cartilage. | The phosphate buffer maintains a stable, near-physiological pH (~7.4) while the saline provides isotonic conditions, protecting peptides and proteins from pH-driven degradation during dissolution and handling. |
| Molecular weight | 4000-6000 Da (average) | Buffered salt solution |
| Half-life | ~24 hours | N/A (solvent) |
| Bioavailability | ~3-6% oral; higher via injection | N/A (diluent) |
| Typical dose | 100 mg | Volume to reach target concentration |
| Frequency | 3x daily (oral) | As needed to reconstitute |
| Route | Oral or subcutaneous injection | Added to peptide/protein vial |
Pentosan Polysulfate reported benefits
- Bladder wall protection
- Cartilage repair support
- Anti-inflammatory action
- Joint pain reduction
Phosphate Buffered Saline reported benefits
- Maintains stable physiological pH
- Isotonic and gentle on peptides/proteins
- Neutral research-grade diluent
Related comparisons
Research and educational reference only. Not medical advice.